Tag Archives: $SVNT

No, the Broncos did not have gout, but they sure looked slow and in pain against the Pats

Posted on January 15, 2012 by BioChef in Training

(Ack.  Wrote this on Friday, and completely forget to post) Here we go – I can’t compete with all the goodies the came out from the JPM Healthcare Conference, but here’s Part II of my six-month update from June. No, … Continue reading →

Posted in Update | Tagged , , , , , , , | Leave a comment

Expect the unexpected

Posted on June 13, 2011 by BioChef in Training

In biotech, always expect the unexpected. Over the past 9-mo, Savient Pharmaceuticals ($SVNT) has seen its market cap explode to $1.6B with Krystexxa (pegloticase) approval for treatment refractory gout, only to see its value fall past its pre-approval valuation of … Continue reading →

Posted in Up and Down | Tagged , , , | Leave a comment